Intelligent Infusion System
Our priority device, Immix, is an intelligent infusion system designed to revolutionize the way infusions are delivered.
What is the problem?
Over 80% of US medical facilities report anesthesia services shortage
Many cases are delayed or cancelled due to this shortage, impacting patient health and outcomes
Medical facilities reporting a shortage rose from 35% in 2020 to ~80% in 2022
The projected 2033 shortage of 12,500 anesthesiologists is ~30% of the current workforce
Procedures requiring anesthesia are expected to increase by 25% over the next 10 years in the US
Existing infusion pumps were responsible for 700+ deaths and 56,000 serious injuries in a 4-year study
Our solution
IMMIX will automate the process of sedation and maintain the patient sedated in a safe manner. As a result, a trained sedation nurse can monitor the patient and no anesthesiologist would be needed. Surgeries that require general anesthesia would proceed with an anesthesiologist supervising up to three rooms. This would offer a tremendous increase in access to procedures and surgeries while reducing cost of anesthesia services to the healthcare system.
IMMIX also offers intrinsically safer medication set up for simple infusions. By design it is aimed to prevent medication errors and be a plug-and-play system for healthcare providers all across the hospital system. We have identified more than 10 major new features and consider IMMIX a true gamer-changer when it comes to starting infusions not only in the perioperative period but across all settings in the hospital system as well as surgery centers and home health settings.
We have a growing coalition of physicians across the United States and several other countries who have endorsed IMMIX’s development. Almost all our investors are physicians from prominent academic, private hospitals and medical groups.
